Haematological safety of long-term therapy with linezolid.
Garazzino
Silvia
S
De Rosa
Francesco Giuseppe
FG
Bargiacchi
Olivia
O
Audagnotto
Sabrina
S
Maiello
Agostino
A
Di Perri
Giovanni
G
D000081:Acetamides / Q000009:adverse effects* / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000890:Anti-Infective Agents / Q000009:adverse effects* / Q000627:therapeutic use; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D006402:Hematologic Diseases / Q000139:chemically induced*; D006801:Humans; D000069349:Linezolid; D008297:Male; D016106:Methicillin Resistance; D008875:Middle Aged; D023303:Oxazolidinones / Q000009:adverse effects* / Q000627:therapeutic use; D011446:Prospective Studies; D012293:Rifampin / Q000627:therapeutic use; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000382:microbiology; D013211:Staphylococcus aureus / Q000187:drug effects; D013921:Thrombocytopenia / Q000139:chemically induced
D000081:Acetamides; D000890:Anti-Infective Agents; D023303:Oxazolidinones; D000069349:Linezolid; D012293:Rifampin